利尿剂与液体扩容在血压正常急性肺栓塞初始治疗中的比较:系统综述与荟萃分析
该系统综述与荟萃分析比较利尿剂与液体扩容在血压正常伴右心室功能不全的急性肺栓塞患者中的疗效。共纳入4项随机对照试验、452例患者。利尿剂组24小时N末端B型利钠肽原(标准均数差-41.97,95%CI -65.79至-18.15)和肺动脉收缩压(标准均数差-5.96,95%CI -8.06至-3.86)显著降低,但肌酐水平显著升高(标准均数差7.74,95%CI 5.04至10.45)。研究质量异质,2项低偏倚风险、2项高偏倚风险。作者认为呋塞米似乎可减轻右心室功能不全,但需进一步研究确认。
要点
- 在血压正常伴右心室功能不全的急性肺栓塞患者中,利尿剂组24小时N末端B型利钠肽原较对照组显著降低(标准均数差-41.97,95%CI -65.79至-18.15)。
- 利尿剂组24小时肺动脉收缩压显著降低(标准均数差-5.96,95%CI -8.06至-3.86)。
- 利尿剂组肌酐水平显著高于对照组(标准均数差7.74,95%CI 5.04至10.45)。
- 纳入4项随机对照试验共452例患者,研究质量异质:2项低偏倚风险、2项高偏倚风险。
- 作者认为呋塞米似乎可减轻该亚组患者的右心室功能不全,但需进一步研究确认。
适用人群与场景
- 血压正常(血流动力学稳定)伴右心室功能不全的急性肺栓塞患者。
处置流程与药物剂量
- 作者认为,与液体扩容相比,呋塞米似乎可减轻该亚组患者的右心室功能不全。
研究设计与关键结果
- 研究类型:系统综述与荟萃分析,仅纳入随机对照试验,检索截至2022年11月1日的传统与灰色文献,采用逆方差固定效应模型、以OR为效应量。
- 共纳入4项研究、452例患者,各研究基线特征相似。
- 利尿剂组24小时N末端B型利钠肽原显著降低(标准均数差-41.97,95%CI -65.79至-18.15)。
- 利尿剂组24小时肺动脉收缩压显著降低(标准均数差-5.96,95%CI -8.06至-3.86)。
- 利尿剂组肌酐水平显著升高(标准均数差7.74,95%CI 5.04至10.45)。
- 研究质量异质:2项低偏倚风险,2项高偏倚风险。
证据类型、等级与局限
- 证据类型:系统综述与荟萃分析(仅纳入随机对照试验)。
- 研究质量异质:2项低偏倚风险,2项高偏倚风险。
- 局限:比较利尿剂与液体扩容疗效与安全性的研究非常少;需进一步研究确认这些发现。
对床旁实践的改变
- 作者认为,在血压正常伴右心室功能不全的急性肺栓塞患者中,与液体扩容相比,呋塞米似乎可减轻右心室功能不全。
- 利尿剂组肌酐水平显著升高(标准均数差7.74,95%CI 5.04至10.45),提示使用利尿剂时需关注肾功能变化。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Right ventricular (RV) dysfunction is the main cause of death in patients with normotensive acute pulmonary embolism (PE). The optimal management for this subset of patients remains uncertain. This systematic review and meta-analysis focused on the comparison of diuretics and fluid expansion in patients with acute PE presenting with RV dysfunction and haemodynamic stability.
METHODS: A systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines considering only RTCs. The authors searched the traditional and grey literature through 1 November 2022. Meta-analysis used open source packages in R. Inverse variance fixed-effects models with OR as the effect measure were used for primary analyses. The main outcomes defined in this review protocol included pulmonary arterial systolic pressure (PASP), creatinine value changes and N-terminal pro-B-type natriuretic peptide during the first 24 hours.
RESULTS: Four studies with a total of 452 patients met the inclusion criteria. The baseline characteristics of patients were similar across all studies. Overall, patients receiving diuretics had a significant 24 hours reduction in pro-B-type natriuretic peptide (standard mean difference of -41.97; 95% CI -65.79 to -18.15), and PASP (standard mean difference of -5.96; 95% CI -8.06 to -3.86). This group had significantly higher creatinine levels (standard mean difference of 7.74; 95% CI 5.04 to 10.45). The quality of the studies was heterogeneous; two had a low risk of bias, and the other two had a high risk of bias.
CONCLUSIONS: Very few studies have compared the efficacy and safety of diuretics and fluid expansion in normotensive patients with acute PE with RV failure. Overall, furosemide appears to reduce RV dysfunction in this subset of patients compared with fluid expansion. Further research is required to confirm these findings.
参考来源
- Febra C, Santos AR, Cabrita I, et al. Comparison of diuretics and fluid expansion in the initial treatment of patients with normotensive acute pulmonary embolism: a systematic review and meta-analysis. Emerg Med J. 2024. PMID: 38253364. doi:10.1136/emermed-2023-213525
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。